A Clinical Trial to Investigate the Efficacy of a Supplement to Improve and Maintain Cognitive Function and Memory

Status unconfirmed · Not applicable · Has a placebo group

Conditions studied: Cognitive Decline, Cognitive Function

In brief

This study will evaluate the efficacy of 1MD Nutrition's MindMD supplement in improving and maintaining cognitive function and memory. The randomized controlled trial will include 50 healthy participants aged 50-75 years, lasting for 3 months. Participants will be randomized to receive either the test product or a placebo.

Key facts

Study ID

NCT06523218

Run by

Scale Media Inc

People needed

50

Starts

2024-05-17

Expected to finish

2024-08-17

Last updated by the study team

2024-07-26

Who can join

Age: 50 and older, up to 75. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Age 50-75 years
• Regular experience of symptoms related to cognitive decline (e.g., forgetfulness, lack of focus, brain fog)
• Generally healthy without uncontrolled chronic diseases
• Willingness to avoid certain medications and supplements during the study

You may not qualify if…

• Any medical condition or treatment impacting cognitive ability Mental health or neurological disorders
• Severe allergies, particularly to soy or other product ingredients
• Taking blood thinning medication
• Recent or planned surgeries
• Major illness in the past three months

Where it is running

• Citruslabs — Santa Monica, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.